Myrexis (MYRX) Return on Equity ROE from the fourth quarter 2013 to fourth quarter 2012 and annually, average high and low, overall ranking from Jun 30 2013 to Jun 30 2012 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Myrexis, Inc.  (MYRX)

Myrexis's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Myrexis in the fourth quarter 2013?
Myrexis, Inc. recorded a cumulative net loss of $-12 million during 12 months ending in the fourth quarter 2013, resulting in a negative return on equity (ROE) of -27.21%.

Within the Biotechnology & Pharmaceuticals industry 11 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the third quarter 2013 from 0 to 1253.

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Jun 30 2013)
IV. Quarter		 (Mar 31 2013)
III. Quarter		 (Dec 31 2012)
II. Quarter		 (Sep 30 2012)
I. Quarter		 (Jun 30 2012)
IV. Quarter
Y / Y Equity Change -98.7 % -98.59 % -20.4 % -21.56 % -
Y / Y Net Income Change - - - - -
Net Income (TTM) in Millions -12 -11 -19 -22 -27
Return On Equity (TTM) -27.21 % -17.71 % -21.55 % -23.24 % -27.06 %
MYRX's Total Ranking # 1253 # 0 # 0 # 0 # 0
Equity (TTM) in Millions 1 1 82 86 89
Seq. Equity Change -11.56 % -98.4 % -4.55 % -3.61 % -4.34 %
Seq. Net Income Change - - - - -

Back to MYRX Management Effectiveness >> MYRX's 5 Years Annual ROE >> Compare MYRX ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry # 12
Sector # 70
Overall # 1253

Return On Equity Statistics
High Average Low
-27.21 %
-27.21 %
-27.21 %
(Jun 30 2013)  





MYRX Annual Return On Equity (Jun 30 2013)
2013		 (Jun 30 2012)
2012


Total Equity in Millions 1 89 0 0 0
Y / Y Equity Change -98.7 % - - - -
Net Income in Millions -12 -31 0 0 0
Y / Y Net Income Change - - - - -
Return On Equity -999.23 % -34.92 % - - -

Back to MYRX Management Effectiveness >> MYRX's 5 Years Annual ROE >> Compare MYRX ROE to its Competitors




More Return On Equity Ratios
Biotechnology & Pharmaceuticals Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
MYRX's' Return on Equity at Yahoo Finance
MYRX's Roe Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for MYRX's Competitors
Subscribers only: Roe for Myrexis's Suppliers
Subscribers only: Return On Equity for MYRX's Customers




Companies with similar Return On Equity at Jun 30 2013, within Healthcare Sector ROE

Date modified: 2026-07-10T08:33:08+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.